Genetics of Diabetes Mellitus and Diabetes Complications

Overview

Journal Nat Rev Nephrol

Specialty Nephrology

Date 2020 May 14

PMID 32398868

Citations 480

Authors

Joanne B Cole

Jose C Florez

Affiliations

Soon will be listed here.

Abstract

Diabetes is one of the fastest growing diseases worldwide, projected to affect 693 million adults by 2045. Devastating macrovascular complications (cardiovascular disease) and microvascular complications (such as diabetic kidney disease, diabetic retinopathy and neuropathy) lead to increased mortality, blindness, kidney failure and an overall decreased quality of life in individuals with diabetes. Clinical risk factors and glycaemic control alone cannot predict the development of vascular complications; numerous genetic studies have demonstrated a clear genetic component to both diabetes and its complications. Early research aimed at identifying genetic determinants of diabetes complications relied on familial linkage analysis suited to strong-effect loci, candidate gene studies prone to false positives, and underpowered genome-wide association studies limited by sample size. The explosion of new genomic datasets, both in terms of biobanks and aggregation of worldwide cohorts, has more than doubled the number of genetic discoveries for both diabetes and diabetes complications. We focus herein on genetic discoveries for diabetes and diabetes complications, empowered primarily through genome-wide association studies, and emphasize the gaps in research for taking genomic discovery to the next level.

Citing Articles

Regulation of the immune microenvironment by SUMO in diabetes mellitus.

Zhuo Y, Fu S, Qiu Y Front Immunol. 2025; 16:1506500.

PMID: 40078991 PMC: 11896877. DOI: 10.3389/fimmu.2025.1506500.

Flavonoid-Rich Extracts from Chuju ( L.) Alleviate the Disturbance of Glycolipid Metabolism on Type 2 Diabetic Mice via Modulating the Gut Microbiota.

Yin Y, Nie W, Tang Z, Zhu S Foods. 2025; 14(5).

PMID: 40077469 PMC: 11898795. DOI: 10.3390/foods14050765.

Single-Nucleotide Polymorphisms in the Thioredoxin Antioxidant System and Their Association with Diabetic Nephropathy in Slovenian Patients with Type 2 Diabetes-A Preliminary Study.

Letonja J, Nussdorfer P, Petrovic D Int J Mol Sci. 2025; 26(5).

PMID: 40076459 PMC: 11899783. DOI: 10.3390/ijms26051832.

Preparation, Structure, Function, and Application of Dietary Polysaccharides from in the Food Industry: A Review.

Li P, Yao H, Yue H, Huang J, Wang Q, Ding C Molecules. 2025; 30(5).

PMID: 40076321 PMC: 11901943. DOI: 10.3390/molecules30051098.

Dietary total antioxidant capacity and risk of prediabetes and diabetes mellitus: a systematic review and dose-response meta-analysis of 170,919 participants.

Li R, Shu L, Zhu Q, Lu D Front Nutr. 2025; 12:1541734.

PMID: 40070482 PMC: 11893433. DOI: 10.3389/fnut.2025.1541734.

References

Janssen B, Hohenadel D, Brinkkoetter P, Peters V, Rind N, Fischer C . Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1. Diabetes. 2005; 54(8):2320-7. DOI: 10.2337/diabetes.54.8.2320. View

Prasad R, Groop L . Genetics of type 2 diabetes-pitfalls and possibilities. Genes (Basel). 2015; 6(1):87-123. PMC: 4377835. DOI: 10.3390/genes6010087. View

Liyanage T, Ninomiya T, Jha V, Neal B, Patrice H, Okpechi I . Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015; 385(9981):1975-82. DOI: 10.1016/S0140-6736(14)61601-9. View

Dyck P, Kratz K, Karnes J, Litchy W, Klein R, Pach J . The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993; 43(4):817-24. DOI: 10.1212/wnl.43.4.817. View

Gerstein H, Miller M, Ismail-Beigi F, Largay J, McDonald C, Lochnan H . Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial. Lancet. 2014; 384(9958):1936-41. PMC: 4397008. DOI: 10.1016/S0140-6736(14)60611-5. View

Earle K, Walker J, Hill C, Viberti G . Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy. N Engl J Med. 1992; 326(10):673-7. DOI: 10.1056/NEJM199203053261005. View

Nathan D, Genuth S, Lachin J, Cleary P, Crofford O, Davis M . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329(14):977-86. DOI: 10.1056/NEJM199309303291401. View

Langenberg C, Lotta L . Genomic insights into the causes of type 2 diabetes. Lancet. 2018; 391(10138):2463-2474. DOI: 10.1016/S0140-6736(18)31132-2. View

Zinman B, Lachin J, Inzucchi S . Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med. 2016; 374(11):1094. DOI: 10.1056/NEJMc1600827. View

10.

Tesfaye S, Stevens L, Stephenson J, Fuller J, Plater M, Ionescu-Tirgoviste C . Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia. 1996; 39(11):1377-84. DOI: 10.1007/s001250050586. View

11.

Gorski M, van der Most P, Teumer A, Chu A, Li M, Mijatovic V . 1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function. Sci Rep. 2017; 7:45040. PMC: 5408227. DOI: 10.1038/srep45040. View

12.

Pettitt D, Saad M, BENNETT P, Nelson R, Knowler W . Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1990; 33(7):438-43. DOI: 10.1007/BF00404096. View

13.

Ge Y, Onengut-Gumuscu S, Quinlan A, Mackey A, Wright J, Buckner J . Targeted Deep Sequencing in Multiple-Affected Sibships of European Ancestry Identifies Rare Deleterious Variants in PTPN22 That Confer Risk for Type 1 Diabetes. Diabetes. 2015; 65(3):794-802. PMC: 4764149. DOI: 10.2337/db15-0322. View

14.

de Ferranti S, de Boer I, Fonseca V, Fox C, Golden S, Lavie C . Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Circulation. 2014; 130(13):1110-30. DOI: 10.1161/CIR.0000000000000034. View

15.

Sandholm N, Salem R, McKnight A, Brennan E, Forsblom C, Isakova T . New susceptibility loci associated with kidney disease in type 1 diabetes. PLoS Genet. 2012; 8(9):e1002921. PMC: 3447939. DOI: 10.1371/journal.pgen.1002921. View

16.

Fall T, Hagg S, Magi R, Ploner A, Fischer K, Horikoshi M . The role of adiposity in cardiometabolic traits: a Mendelian randomization analysis. PLoS Med. 2013; 10(6):e1001474. PMC: 3692470. DOI: 10.1371/journal.pmed.1001474. View

17.

Imperatore G, Hanson R, Pettitt D, Kobes S, BENNETT P, Knowler W . Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. Diabetes. 1998; 47(5):821-30. DOI: 10.2337/diabetes.47.5.821. View

18.

Scott R, Scott L, Magi R, Marullo L, Gaulton K, Kaakinen M . An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans. Diabetes. 2017; 66(11):2888-2902. PMC: 5652602. DOI: 10.2337/db16-1253. View

19.

McCarthy S, Das S, Kretzschmar W, Delaneau O, Wood A, Teumer A . A reference panel of 64,976 haplotypes for genotype imputation. Nat Genet. 2016; 48(10):1279-83. PMC: 5388176. DOI: 10.1038/ng.3643. View

20.

Barrett J, Clayton D, Concannon P, Akolkar B, Cooper J, Erlich H . Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet. 2009; 41(6):703-7. PMC: 2889014. DOI: 10.1038/ng.381. View